Support: 888-992-3836
Copyright © 2023 InvestorsHub Inc.
Replies to post #809 on Correvio Pharma (CORV)
MMMQA
02/28/20 3:34 PM
#810 RE: LINK Oracle #809
02/28/20 3:40 PM
#811 RE: LINK Oracle #809
The Company's portfolio of approved and marketed brands includes: Xydalba™ (dalbavancin hydrochloride)